Cerebral Palsy Center reports Kidswell Bio is advancing stem cell therapy for cerebral palsy in the U.S., focusing on cells ...
CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine ...
A CAR-T cell therapy has successfully treated not one, not two, but three different autoimmune diseases at once in a patient, ...
The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen ...
Worth up to $7 billion, Lilly’s second recent acquisition of a company in the space is centered around a cell therapy that’s ...
Results of the single-center, phase 2 CAR-PRISM (PRecision Intervention Smoldering Myeloma) clinical trial, the first to ...
Novo Nordisk will be happy with the results after Pfizer has dropped two SCD assets in recent years. Credit: JHVEPhoto / ...
A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in ...
Live Science on MSN
$3 million prize goes to duo whose research led to first sickle cell CRISPR therapy
Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...
A few transplant patients in a small study were able to stop using immunosuppressive drugs, thanks to pre-transplant cell ...
The combined company will trade on the Nasdaq under the ticker OBX. It has also secured commitments for a private placement ...
The Sarah Cannon Transplant & Cellular Therapy Program at St. David's South Austin Medical Center is among a select group of organizations participating in a global clinical trial to examine the next ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results